Study of YK012 in B-cell Acute Lymphoblastic Leukemia

Clinical trial NCT06580301 · RECRUITING

Trial details

NCT number: NCT06580301
Sponsor: Excyte Biopharma Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2024-09-25
Primary completion: 2026-12-31
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.